GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become popular when used as a weight loss drug. But, experts warn there can be ...

These are some of the trends in weight management retailers and manufacturers are keeping an eye on in the new year to help ...

The PRAC still has another safety review on the go for the GLP-1 ... side effects that can be caused by Ozempic and Mounjaro (tirzepatide), Lilly’s dual GLP-1/GIP agonist.

Use of the GLP-1 agonist was associated, however, with an increased risk of side effects, particularly gastrointestinal symptoms such as nausea, which occurred in nearly half of patients.